Necrotizing fasciitis: A complication of percutaneous coronary revascularization

Angiology

Volumn 58, Issue 3, 2007, Pages 360-366

  Calderon, Eduardo ^a,b   Carter, Eliott ^a   Ramsey, Keith M ^a   Vande Waa, John A ^a   Green, William K ^a   Alpert, Martin A ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLINDAMYCIN; CLOPIDOGREL; ENALAPRIL; GENTAMICIN; GLYCERYL TRINITRATE; HEPARIN; METOPROLOL; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DEBRIDEMENT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEPARINIZATION; HUMAN; HYPERBARIC OXYGEN; MALE; MUSCLE FLAP; NECROTIZING FASCIITIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; SKIN GRAFT; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; FASCIITIS, NECROTIZING; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; PEPTOSTREPTOCOCCUS; PROPIONIBACTERIUM; SKIN TRANSPLANTATION; STENTS; TREATMENT OUTCOME;

EID: 34250723900     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707301752     Document Type: Article

References (40)

1. Landau C., Lange RA, Hillis LD: Percutaneous transluminal coronary angioplasty. N Engl J Med 330: 981-993, 1994.
2. Oweida SW, Roubin GS, Smith III BR,, et al. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg 12: 310-315, 1990.
3. Shea KW, Schwartz RK, Gambino AT,, et al. Bacteremia associated with percutaneous transluminal coronary angioplasty. Cath Card Diag 36: 5-9, 1995.
4. James E., Broadhurst P., Simpson A.,, et al. Bacteremia complicating coronary artery stenting. J Hosp Infect 38: 154-155, 1998.
5. Banai S., Selitzer V., Keren A.,, et al. Prospective study of bacteremia after cardiac catheterization. Am J Cardiol 92: 1004-1007, 2003.
6. McGready RA, Siderys H., Pittman JN,, et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg 14: 170-174, 1991.
7. Bouchart F., Dubar A., Bessou JP,, et al. Pseudomonas aeruginosa coronary stent infection. Ann Thorac Surg 64: 1810-1813, 1997.
8. Leroy O., Martin E., Prat A.,, et al. Fatal infection of coronary stent implantation. Cath Card Diag 39: 168-170, 1996.
9. Grewe PH, Machraoui A., Deneke T.,, et al. Suppurative pancarditis: A lethal complication of coronary stent implantation. Heart 81: 559-560, 1999.
10. Gunther HU, Strupp G., Volmar J.,, et al. Coronary stent implantation: Infection and abscess with fatal outcome. Z Kardiol 83: 521-525, 1993.
11. Timsit J-F., Wolff MA, Bedos JP: Cardiac abscess following percutaneous transluminal coronary angioplasty. Chest 103: 639-641, 1993.
12. Krupski WC, Pogany A., Effeney DJ: Septic endarteritis due to Staphylococcus aureus complicating percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 98: 359-361, 1985.
13. Brummitt CF, Kravitz GR, Granrud GA,, et al. Femoral endarteritis due to Staphylococcus aureus complicating percutaneous transluminal coronary angioplasty. Am J Med 86: 822-889, 1989.
14. Frazee BW, Flaherty JP: Septic endarteritis of the femoral artery following angioplasty. Rev Infect Dis 13: 620-623, 1991.
15. Smith TP, Cruz C., Moursi MM,, et al. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg 182: 658-662, 2001.
16. Cooper CL, Miller A.: Infectious complications related to the use of the Angio-Seal Hemostatic Puncture Closure Device. Cath Cardiovasc Interven 48: 301-303, 1999.
17. Herchline T., Carey D.: Infected pseudoaneurysm complicating percutaneous transluminal coronary angioplasty. Clin Infect Dis 22: 602, 1996.
18. Cleveland KO, Gelfand MS: Invasive staphylococcal infections complicating percutaneous transluminal coronary angioplasty: Three cases and review. Clin Infect Dis 21: 93-96, 1995.
19. Wiener RS, Ong LS: Local infection after percutaneous transluminal coronary angioplasty: Relation to early repuncture of ipsilateral femoral artery. Cath Card Diag 16: 180-181, 1989.
20. DeJong B.: Groin infection following cardiac catheterization: A case report. South Dakota J Med 45: 345-346, 1992.
21. Shea KW, Cunha BA: Invasive staphylococcal infections complicating percutaneous transluminal coronary angioplasty. Clin Infect Dis 22: 601, 1996.
22. Evans BH, Goldstein Ejc: Increased risk of infection after repeat percutaneous transluminal coronary angioplasty. Am J Inf Control 15: 125-126, 1987.
23. Yamamoto N., Koyano K., Azuma M.,, et al. Groin infection caused by a percutaneous femoral artery closure device: Report of a case. Surg Today 33: 801-804, 2003.
24. Stevens DL: Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 51: 271-288, 2000.
25. Swartz MN: Cellulitis and subcutaneous tissue infections. In: Mandell GL, Bennett JE, and Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5 th ed. Philadelphia, PA: Churchill Livingstone ; 2000: 1037-1055.
26. Green RF, Dafoe DC, Raffin TA: Necrotizing fasciitis. Chest 110: 219-229, 1996.
27. Seal DV: Necrotizing fasciitis. Curr Opin Infect Dis 14: 127-132, 2001.
28. Federman DG, Kravetz JD, Kissner RS: Necrotizing fasciitis and cardiac catheterization. Cutis 73: 49-52, 2004.
29. Chen JL, Fullerton KE, Flynn NM: Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 33: 6-15, 2001.
30. Brook I.: Peptostreptococcal infection in children. Scand J Infect Dis 26: 503-510, 1994.
31. Polgreen PM, Dickema DJ, VandeBerg J.,, et al. Risk factors for groin wound infection after femoral artery catheterization: A case-control study. Infect Control Hosp Epidemiol 27: 34-37, 2006.
32. Nikolsky E., Mehran R., Halkin A.,, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures. J Am Coll Cardiol 44: 1200-1209, 2004.
33. Letzalter C., Croutte F., Pianezzi B.,, et al. Supernatant cytotoxicity and proteolytic activity of selected oral bacteria against human gingival fibroblast in vitro. Arch Oral Biol 43: 15-23, 1998.
34. Mikano H., Kawazoe K., Sato Y.,, et al. Elastase activity of anaerobes isolated from amniotic fluid with preterm premature rupture of membranes. Am J Obstet and Gynecol 180: 378-380, 1999.
35. Krepel CJ, Gohr CM, Edmiston CE,, et al. Anaerobic pathogenesis: Collagenase production by Peptostreptococcus magnus and its relationship to site of infection. J Infect Dis 163: 1148-1150, 1991.
36. Ng J., Ng LK, Mayrand D.,, et al. Aminopeptidase activities in peptostreptococcus are statistically correlated to gelatin hydrolysis. Can J Microbiol 44: 303-306, 1998.
37. Sjobring U., Trojnar J., Grubb A.,, et al. Ig-binding bacterial proteins also bind proteinase inhibitors. J Immunol 143: 2948-2954, 1989.
38. Patella V., Casolaro V., Bjorck L., Marone G.: A bacterial Ig-binding protein that activates human basophils and mast cells. J Immunol 145: 3054-3061, 1990.
39. de Chateau M., Holst E., Bjorck L.: Protein PAB, an albumin-binding bacterial surface protein promoting growth and virulence. J Biol Chem 271: 26609-26615, 1996.
40. Tam YC, Chan BC: Purification and characterization of hyaluronidase from oral Peptostreptococcus species. Infect Immun 47: 508-513, 1985.